Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 337

1.

Variability in Probiotic Formulations Revealed by Proteomics and Physico-chemistry Approach in Relation to the Gut Permeability.

Razafindralambo H, Correani V, Fiorucci S, Mattei B.

Probiotics Antimicrob Proteins. 2019 Sep 3. doi: 10.1007/s12602-019-09590-1. [Epub ahead of print]

PMID:
31482402
2.

Corrigendum: Conserved Residues Control the T1R3-Specific Allosteric Signaling Pathway of the Mammalian Sweet-Taste Receptor.

Chéron JB, Soohoo A, Wang Y, Golebiowski J, Antonczak S, Jiang P, Fiorucci S.

Chem Senses. 2019 Oct 17;44(8):649-650. doi: 10.1093/chemse/bjz038. No abstract available.

3.

The Aryl Hydrocarbon Receptor (AhR) Mediates the Counter-Regulatory Effects of Pelargonidins in Models of Inflammation and Metabolic Dysfunctions.

Biagioli M, Carino A, Fiorucci C, Annunziato G, Marchianò S, Bordoni M, Roselli R, Giorgio CD, Castiglione F, Ricci P, Bruno A, Faccini A, Distrutti E, Baldoni M, Costantino G, Fiorucci S.

Nutrients. 2019 Aug 7;11(8). pii: E1820. doi: 10.3390/nu11081820.

4.

Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH.

Carino A, Biagioli M, Marchianò S, Fiorucci C, Zampella A, Monti MC, Scarpelli P, Ricci P, Distrutti E, Fiorucci S.

Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1422-1437. doi: 10.1016/j.bbalip.2019.07.006. Epub 2019 Jul 17.

PMID:
31325638
5.

Chenodeoxycholic Acid: An Update on Its Therapeutic Applications.

Fiorucci S, Distrutti E.

Handb Exp Pharmacol. 2019;256:265-282. doi: 10.1007/164_2019_226. Review.

PMID:
31267167
6.

GPBAR1 Functions as Gatekeeper for Liver NKT Cells and provides Counterregulatory Signals in Mouse Models of Immune-Mediated Hepatitis.

Biagioli M, Carino A, Fiorucci C, Marchianò S, Di Giorgio C, Roselli R, Magro M, Distrutti E, Bereshchenko O, Scarpelli P, Zampella A, Fiorucci S.

Cell Mol Gastroenterol Hepatol. 2019;8(3):447-473. doi: 10.1016/j.jcmgh.2019.06.003. Epub 2019 Jun 18.

7.

The Pharmacology of Bile Acids and Their Receptors.

Fiorucci S, Distrutti E.

Handb Exp Pharmacol. 2019;256:3-18. doi: 10.1007/164_2019_238. Review.

PMID:
31201555
8.

Obeticholic Acid: An Update of Its Pharmacological Activities in Liver Disorders.

Fiorucci S, Di Giorgio C, Distrutti E.

Handb Exp Pharmacol. 2019;256:283-295. doi: 10.1007/164_2019_227. Review.

PMID:
31201552
9.

Transcriptome Analysis of Dual FXR and GPBAR1 Agonism in Rodent Model of NASH Reveals Modulation of Lipid Droplets Formation.

Carino A, Marchianò S, Biagioli M, Fiorucci C, Zampella A, Monti MC, Morretta E, Bordoni M, Di Giorgio C, Roselli R, Ricci P, Distrutti E, Fiorucci S.

Nutrients. 2019 May 21;11(5). pii: E1132. doi: 10.3390/nu11051132.

10.

Serum Bile Acid Levels Before and After Sleeve Gastrectomy and Their Correlation with Obesity-Related Comorbidities.

De Vuono S, Ricci MA, Nulli Migliola E, Monti MC, Morretta E, Boni M, Ministrini S, Carino A, Fiorucci S, Distrutti E, Lupattelli G.

Obes Surg. 2019 Aug;29(8):2517-2526. doi: 10.1007/s11695-019-03877-6.

PMID:
31069691
11.

Metal Ions Activate the Human Taste Receptor TAS2R7.

Wang Y, Zajac AL, Lei W, Christensen CM, Margolskee RF, Bouysset C, Golebiowski J, Zhao H, Fiorucci S, Jiang P.

Chem Senses. 2019 May 29;44(5):339-347. doi: 10.1093/chemse/bjz024.

12.

Allosteric Modulation Mechanism of the mGluR5 Transmembrane Domain.

Cong X, Chéron JB, Golebiowski J, Antonczak S, Fiorucci S.

J Chem Inf Model. 2019 Jun 24;59(6):2871-2878. doi: 10.1021/acs.jcim.9b00045. Epub 2019 May 3.

PMID:
31025859
13.

Results of a Search for Sub-GeV Dark Matter Using 2013 LUX Data.

Akerib DS, Alsum S, Araújo HM, Bai X, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Boxer B, Brás P, Burdin S, Byram D, Carmona-Benitez MC, Chan C, Cutter JE, Davison TJR, Druszkiewicz E, Fallon SR, Fan A, Fiorucci S, Gaitskell RJ, Genovesi J, Ghag C, Gilchriese MGD, Gwilliam C, Hall CR, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Jacobsen RG, Jahangir O, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Korolkova EV, Kravitz S, Kudryavtsev VA, Lenardo BG, Lesko KT, Liao J, Lin J, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marangou N, Marzioni MF, McKinsey DN, Mei DM, Moongweluwan M, Morad JA, Murphy ASJ, Naylor A, Nehrkorn C, Nelson HN, Neves F, Oliver-Mallory KC, Palladino KJ, Pease EK, Riffard Q, Rischbieter GRC, Rhyne C, Rossiter P, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Utku U, Uvarov S, Velan V, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FLH, Woodward D, Xu J, Yazdani K, Zhang C; LUX Collaboration.

Phys Rev Lett. 2019 Apr 5;122(13):131301. doi: 10.1103/PhysRevLett.122.131301.

14.

Investigation around the Oxadiazole Core in the Discovery of a New Chemotype of Potent and Selective FXR Antagonists.

Festa C, Finamore C, Marchianò S, Di Leva FS, Carino A, Monti MC, Del Gaudio F, Ceccacci S, Limongelli V, Zampella A, Fiorucci S, De Marino S.

ACS Med Chem Lett. 2019 Jan 10;10(4):504-510. doi: 10.1021/acsmedchemlett.8b00534. eCollection 2019 Apr 11.

PMID:
30996787
15.

Novel Isoxazole Derivatives with Potent FXR Agonistic Activity Prevent Acetaminophen-Induced Liver Injury.

Sepe V, Marchianò S, Finamore C, Baronissi G, Di Leva FS, Carino A, Biagioli M, Fiorucci C, Cassiano C, Monti MC, Del Gaudio F, Novellino E, Limongelli V, Fiorucci S, Zampella A.

ACS Med Chem Lett. 2018 Dec 6;10(4):407-412. doi: 10.1021/acsmedchemlett.8b00423. eCollection 2019 Apr 11.

PMID:
30996771
16.

Conserved Residues Control the T1R3-Specific Allosteric Signaling Pathway of the Mammalian Sweet-Taste Receptor.

Chéron JB, Soohoo A, Wang Y, Golebiowski J, Antonczak S, Jiang P, Fiorucci S.

Chem Senses. 2019 May 29;44(5):303-310. doi: 10.1093/chemse/bjz015. Erratum in: Chem Senses. 2019 Oct 17;44(8):649-650.

PMID:
30893427
17.

Introduction of Nonacidic Side Chains on 6-Ethylcholane Scaffolds in the Identification of Potent Bile Acid Receptor Agonists with Improved Pharmacokinetic Properties.

Finamore C, Baronissi G, Marchianò S, Di Leva FS, Carino A, Monti MC, Limongelli V, Zampella A, Fiorucci S, Sepe V.

Molecules. 2019 Mar 16;24(6). pii: E1043. doi: 10.3390/molecules24061043.

18.

Zebrafish olfactory receptors ORAs differentially detect bile acids and bile salts.

Cong X, Zheng Q, Ren W, Chéron JB, Fiorucci S, Wen T, Zhang C, Yu H, Golebiowski J, Yu Y.

J Biol Chem. 2019 Apr 26;294(17):6762-6771. doi: 10.1074/jbc.RA118.006483. Epub 2019 Mar 4.

PMID:
30833327
19.

Discovery of ((1,2,4-oxadiazol-5-yl)pyrrolidin-3-yl)ureidyl derivatives as selective non-steroidal agonists of the G-protein coupled bile acid receptor-1.

Di Leva FS, Festa C, Carino A, De Marino S, Marchianò S, Di Marino D, Finamore C, Monti MC, Zampella A, Fiorucci S, Limongelli V.

Sci Rep. 2019 Feb 21;9(1):2504. doi: 10.1038/s41598-019-38840-z.

20.

Divergent Effectiveness of Multispecies Probiotic Preparations on Intestinal Microbiota Structure Depends on Metabolic Properties.

Biagioli M, Capobianco D, Carino A, Marchianò S, Fiorucci C, Ricci P, Distrutti E, Fiorucci S.

Nutrients. 2019 Feb 2;11(2). pii: E325. doi: 10.3390/nu11020325.

21.

Endocrine activities and adipogenic effects of bisphenol AF and its main metabolite.

Skledar DG, Carino A, Trontelj J, Troberg J, Distrutti E, Marchianò S, Tomašič T, Zega A, Finel M, Fiorucci S, Mašič LP.

Chemosphere. 2019 Jan;215:870-880. doi: 10.1016/j.chemosphere.2018.10.129. Epub 2018 Oct 18.

PMID:
30408883
22.

Agonism for the bile acid receptor GPBAR1 reverses liver and vascular damage in a mouse model of steatohepatitis.

Carino A, Marchianò S, Biagioli M, Bucci M, Vellecco V, Brancaleone V, Fiorucci C, Zampella A, Monti MC, Distrutti E, Fiorucci S.

FASEB J. 2019 Feb;33(2):2809-2822. doi: 10.1096/fj.201801373RR. Epub 2018 Oct 10.

PMID:
30303744
23.

Bile Acids Activated Receptors Regulate Innate Immunity.

Fiorucci S, Biagioli M, Zampella A, Distrutti E.

Front Immunol. 2018 Aug 13;9:1853. doi: 10.3389/fimmu.2018.01853. eCollection 2018. Review.

24.

Future trends in the treatment of non-alcoholic steatohepatitis.

Fiorucci S, Biagioli M, Distrutti E.

Pharmacol Res. 2018 Aug;134:289-298. doi: 10.1016/j.phrs.2018.07.014. Epub 2018 Jul 17. Review.

PMID:
30021122
25.

Activation Dynamics of the Neurotensin G Protein-Coupled Receptor 1.

Cong X, Fiorucci S, Golebiowski J.

J Chem Theory Comput. 2018 Aug 14;14(8):4467-4473. doi: 10.1021/acs.jctc.8b00216. Epub 2018 Jul 25.

PMID:
29965755
26.

Farnesoid X receptor modulators 2014-present: a patent review.

Sepe V, Distrutti E, Fiorucci S, Zampella A.

Expert Opin Ther Pat. 2018 May;28(5):351-364. doi: 10.1080/13543776.2018.1459569. Epub 2018 Apr 13. Review.

PMID:
29649907
27.

Agonists of G-Protein-Coupled Odorant Receptors Are Predicted from Chemical Features.

Bushdid C, de March CA, Fiorucci S, Matsunami H, Golebiowski J.

J Phys Chem Lett. 2018 May 3;9(9):2235-2240. doi: 10.1021/acs.jpclett.8b00633. Epub 2018 Apr 17.

PMID:
29648835
28.

Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.

Fiorucci S, Biagioli M, Distrutti E.

Dig Dis Sci. 2018 Sep;63(9):2168-2171. doi: 10.1007/s10620-018-5039-y. No abstract available.

PMID:
29611077
29.

Disruption of TFGβ-SMAD3 pathway by the nuclear receptor SHP mediates the antifibrotic activities of BAR704, a novel highly selective FXR ligand.

Carino A, Biagioli M, Marchianò S, Scarpelli P, Zampella A, Limongelli V, Fiorucci S.

Pharmacol Res. 2018 May;131:17-31. doi: 10.1016/j.phrs.2018.02.033. Epub 2018 Mar 9.

PMID:
29530598
30.

Genetic and Pharmacological Dissection of the Role of Spleen Tyrosine Kinase (Syk) in Intestinal Inflammation and Immune Dysfunction in Inflammatory Bowel Diseases.

Biagioli M, Mencarelli A, Carino A, Cipriani S, Marchianò S, Fiorucci C, Donini A, Graziosi L, Baldelli F, Distrutti E, Costantino G, Fiorucci S.

Inflamm Bowel Dis. 2017 Dec 19;24(1):123-135. doi: 10.1093/ibd/izx031.

PMID:
29272492
31.

Gpbar1 agonism promotes a Pgc-1α-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice.

Carino A, Cipriani S, Marchianò S, Biagioli M, Scarpelli P, Zampella A, Monti MC, Fiorucci S.

Sci Rep. 2017 Oct 20;7(1):13689. doi: 10.1038/s41598-017-13102-y.

32.

Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity.

Biagioli M, Laghi L, Carino A, Cipriani S, Distrutti E, Marchianò S, Parolin C, Scarpelli P, Vitali B, Fiorucci S.

Front Pharmacol. 2017 Jul 28;8:505. doi: 10.3389/fphar.2017.00505. eCollection 2017.

33.

Nanotraps with biomimetic surface as decoys for chemokines.

Guryanov I, Cipriani S, Fiorucci S, Zashikhina N, Marchianò S, Scarpelli P, Korzhikov-Vlakh V, Popova E, Korzhikova-Vlakh E, Biondi B, Formaggio F, Tennikova T.

Nanomedicine. 2017 Nov;13(8):2575-2585. doi: 10.1016/j.nano.2017.07.006. Epub 2017 Jul 26.

PMID:
28756094
34.

First Searches for Axions and Axionlike Particles with the LUX Experiment.

Akerib DS, Alsum S, Aquino C, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Brás P, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chiller AA, Chiller C, Currie A, Cutter JE, Davison TJR, Dobi A, Dobson JEY, Druszkiewicz E, Edwards BN, Faham CH, Fallon SR, Fiorucci S, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MGD, Hall CR, Hanhardt M, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Jacobsen RG, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Larsen NA, Lee C, Lenardo BG, Lesko KT, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marzioni MF, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad JA, Murphy ASJ, Nehrkorn C, Nelson HN, Neves F, O'Sullivan K, Oliver-Mallory KC, Palladino KJ, Pease EK, Reichhart L, Rhyne C, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Stephenson S, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Uvarov S, Velan V, Verbus JR, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FLH, Xu J, Yazdani K, Young SK, Zhang C; LUX Collaboration.

Phys Rev Lett. 2017 Jun 30;118(26):261301. doi: 10.1103/PhysRevLett.118.261301. Epub 2017 Jun 29.

35.

Limits on Spin-Dependent WIMP-Nucleon Cross Section Obtained from the Complete LUX Exposure.

Akerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Brás P, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chiller AA, Chiller C, Currie A, Cutter JE, Davison TJR, Dobi A, Dobson JEY, Druszkiewicz E, Edwards BN, Faham CH, Fallon SR, Fiorucci S, Gaitskell RJ, Gehman VM, Ghag C, Gilchriese MGD, Hall CR, Hanhardt M, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Jacobsen RG, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Larsen NA, Lee C, Lenardo BG, Lesko KT, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marzioni MF, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad JA, Murphy ASJ, Nehrkorn C, Nelson HN, Neves F, O'Sullivan K, Oliver-Mallory KC, Palladino KJ, Pease EK, Reichhart L, Rhyne C, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Stephenson S, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Uvarov S, Velan V, Verbus JR, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FLH, Xu J, Yazdani K, Young SK, Zhang C; LUX Collaboration.

Phys Rev Lett. 2017 Jun 23;118(25):251302. doi: 10.1103/PhysRevLett.118.251302. Epub 2017 Jun 23.

36.

The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis.

Biagioli M, Carino A, Cipriani S, Francisci D, Marchianò S, Scarpelli P, Sorcini D, Zampella A, Fiorucci S.

J Immunol. 2017 Jul 15;199(2):718-733. doi: 10.4049/jimmunol.1700183. Epub 2017 Jun 12.

37.

Update of the ATTRACT force field for the prediction of protein-protein binding affinity.

Chéron JB, Zacharias M, Antonczak S, Fiorucci S.

J Comput Chem. 2017 Jun 5;38(21):1887-1890. doi: 10.1002/jcc.24836. Epub 2017 Jun 5.

PMID:
28580613
38.

Targeting Bile Acid Receptors: Discovery of a Potent and Selective Farnesoid X Receptor Agonist as a New Lead in the Pharmacological Approach to Liver Diseases.

Festa C, De Marino S, Carino A, Sepe V, Marchianò S, Cipriani S, Di Leva FS, Limongelli V, Monti MC, Capolupo A, Distrutti E, Fiorucci S, Zampella A.

Front Pharmacol. 2017 Mar 30;8:162. doi: 10.3389/fphar.2017.00162. eCollection 2017.

39.

Hyodeoxycholic acid derivatives as liver X receptor α and G-protein-coupled bile acid receptor agonists.

De Marino S, Carino A, Masullo D, Finamore C, Marchianò S, Cipriani S, Di Leva FS, Catalanotti B, Novellino E, Limongelli V, Fiorucci S, Zampella A.

Sci Rep. 2017 Feb 24;7:43290. doi: 10.1038/srep43290.

40.

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis.

Carino A, Cipriani S, Marchianò S, Biagioli M, Santorelli C, Donini A, Zampella A, Monti MC, Fiorucci S.

Sci Rep. 2017 Feb 16;7:42801. doi: 10.1038/srep42801.

41.

Bornyl-diphosphate synthase from Lavandula angustifolia: A major monoterpene synthase involved in essential oil quality.

Despinasse Y, Fiorucci S, Antonczak S, Moja S, Bony A, Nicolè F, Baudino S, Magnard JL, Jullien F.

Phytochemistry. 2017 May;137:24-33. doi: 10.1016/j.phytochem.2017.01.015. Epub 2017 Feb 9.

PMID:
28190677
42.

Results from a Search for Dark Matter in the Complete LUX Exposure.

Akerib DS, Alsum S, Araújo HM, Bai X, Bailey AJ, Balajthy J, Beltrame P, Bernard EP, Bernstein A, Biesiadzinski TP, Boulton EM, Bramante R, Brás P, Byram D, Cahn SB, Carmona-Benitez MC, Chan C, Chiller AA, Chiller C, Currie A, Cutter JE, Davison TJ, Dobi A, Dobson JE, Druszkiewicz E, Edwards BN, Faham CH, Fiorucci S, Gaitskell RJ, Gehman VM, Ghag C, Gibson KR, Gilchriese MG, Hall CR, Hanhardt M, Haselschwardt SJ, Hertel SA, Hogan DP, Horn M, Huang DQ, Ignarra CM, Ihm M, Jacobsen RG, Ji W, Kamdin K, Kazkaz K, Khaitan D, Knoche R, Larsen NA, Lee C, Lenardo BG, Lesko KT, Lindote A, Lopes MI, Manalaysay A, Mannino RL, Marzioni MF, McKinsey DN, Mei DM, Mock J, Moongweluwan M, Morad JA, Murphy AS, Nehrkorn C, Nelson HN, Neves F, O'Sullivan K, Oliver-Mallory KC, Palladino KJ, Pease EK, Phelps P, Reichhart L, Rhyne C, Shaw S, Shutt TA, Silva C, Solmaz M, Solovov VN, Sorensen P, Stephenson S, Sumner TJ, Szydagis M, Taylor DJ, Taylor WC, Tennyson BP, Terman PA, Tiedt DR, To WH, Tripathi M, Tvrznikova L, Uvarov S, Verbus JR, Webb RC, White JT, Whitis TJ, Witherell MS, Wolfs FL, Xu J, Yazdani K, Young SK, Zhang C; LUX Collaboration.

Phys Rev Lett. 2017 Jan 13;118(2):021303. doi: 10.1103/PhysRevLett.118.021303. Epub 2017 Jan 11.

43.

Decoding the role of the nuclear receptor SHP in regulating hepatic stellate cells and liver fibrogenesis.

Cipriani S, Carino A, Masullo D, Zampella A, Distrutti E, Fiorucci S.

Sci Rep. 2017 Jan 24;7:41055. doi: 10.1038/srep41055.

44.

Sweetness prediction of natural compounds.

Chéron JB, Casciuc I, Golebiowski J, Antonczak S, Fiorucci S.

Food Chem. 2017 Apr 15;221:1421-1425. doi: 10.1016/j.foodchem.2016.10.145. Epub 2016 Nov 3.

PMID:
27979110
45.

The anatomy of mammalian sweet taste receptors.

Chéron JB, Golebiowski J, Antonczak S, Fiorucci S.

Proteins. 2017 Feb;85(2):332-341. doi: 10.1002/prot.25228. Epub 2017 Jan 5.

PMID:
27936499
46.

Decoding the vasoregulatory activities of bile acid-activated receptors in systemic and portal circulation: role of gaseous mediators.

Fiorucci S, Zampella A, Cirino G, Bucci M, Distrutti E.

Am J Physiol Heart Circ Physiol. 2017 Jan 1;312(1):H21-H32. doi: 10.1152/ajpheart.00577.2016. Epub 2016 Oct 7. Review.

47.

Receptor-ligand interactions: Advanced biomedical applications.

Guryanov I, Fiorucci S, Tennikova T.

Mater Sci Eng C Mater Biol Appl. 2016 Nov 1;68:890-903. doi: 10.1016/j.msec.2016.07.072. Epub 2016 Jul 28. Review.

PMID:
27524092
48.

New brominated flame retardants and their metabolites as activators of the pregnane X receptor.

Gramec Skledar D, Tomašič T, Carino A, Distrutti E, Fiorucci S, Peterlin Mašič L.

Toxicol Lett. 2016 Sep 30;259:116-123. doi: 10.1016/j.toxlet.2016.08.005. Epub 2016 Aug 6.

PMID:
27506419
49.

Highly specific blockade of CCR5 inhibits leukocyte trafficking and reduces mucosal inflammation in murine colitis.

Mencarelli A, Cipriani S, Francisci D, Santucci L, Baldelli F, Distrutti E, Fiorucci S.

Sci Rep. 2016 Aug 5;6:30802. doi: 10.1038/srep30802.

50.

Targeting the transsulfuration-H2S pathway by FXR and GPBAR1 ligands in the treatment of portal hypertension.

Fiorucci S, Distrutti E.

Pharmacol Res. 2016 Sep;111:749-756. doi: 10.1016/j.phrs.2016.07.040. Epub 2016 Jul 27. Review.

PMID:
27475883

Supplemental Content

Loading ...
Support Center